Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Generics
Filter     Order     Display # 
Date Item Title
10 Jun 2006 Synovics Pharmaceuticals Initiates U.S. Development of Its Third Generic Oral Controlled-Release Drug
07 Jun 2006 Lupin Announces Final FDA Approval of Cefdinir for Oral Suspension
03 Jun 2006 Ranbaxy Receives Approval From US FDA To Market Doxycycline Tablets
02 Jun 2006 Imminent launches of new EPO products and consolidation of the biogenerics field
02 Jun 2006 Watson Pharmaceuticals Receives FDA Approval for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1mg / 0.02mg
31 May 2006 Sandoz gets precedent-setting US approval for Omnitrope as first followon version of a previously approved recombinant biotechnology drug
30 May 2006 Actavis launches three new generic products in Europe
29 May 2006 Teva Announces Tentative Approval for Generic Cozaar(R) Tablets
27 May 2006 Lupin Announces Final FDA Approval of Cefdinir Capsules
26 May 2006 Teva Announces Tentative Approval of Simvastatin Tablets
25 May 2006 Mylan Announces Tentative Approval for Sumatriptan Succinate Tablets
23 May 2006 Teva Announces Approval Of Generic Lexapro® Tablets
19 May 2006 FDA Gives Tentative Approval to New Generic AIDS Drug in Association with the President’s Emergency Plan for AIDS Relief
18 May 2006 The next generation of interferons needs improvement in efficacy and safety
13 May 2006 Barr Receives Approval for Isotretinoin Capsules USP, 30 mg
08 May 2006 Teva Announces Approval Of Polyethylene Glycol 3350 NF For Oral Solution
04 May 2006 Biopartners Receives European Union Marketing Authorisation for its Biosimilar Recombinant Human Growth Hormone - Valtropin(R)
03 May 2006 IMPAX Receives FDA Approval for Generic Version of Colestid(R); Global Pharmaceuticals Division to Launch
03 May 2006 Scigen Ltd Signs An Exclusive Worldwide Supply Agreement For GCSF & EPO
25 Apr 2006 Mylan Announces Final FDA Approval for Cilostazol Tablets
25 Apr 2006 India's Aurobindo Pharma gets tentative FDA approval for Simvastatin
24 Apr 2006 Taro Receives Tentative ANDA Approvals For Carvedilol Tablets and Ondansetron HCL Tablets
24 Apr 2006 Teva Receives Tentative Approval for Generic Protonix® Delayed Release Tablets, 20 Mg And 40 Mg
19 Apr 2006 Mylan Announces Tentative Approval for Finasteride Tablets USP, 5mg
13 Apr 2006 Mylan Announces Tentative Approval for Fexofenadine Hydrochloride Tablets
13 Apr 2006 Teva Announces Approval Of Mitoxantrone Hydrochloride Injection USP
12 Apr 2006 Mayne Announces FDA Approval of Mitoxantrone
12 Apr 2006 American Pharmaceutical Partners Adds to Its Broad Oncology Portfolio with the Approval of Mitoxantrone Injection, USP
12 Apr 2006 Mayne Pharma USA Inc. Announces FDA Approval Of Mitoxantrone
06 Apr 2006 IMPAX Receives FDA Approval for Generic Version of SALAGEN(R) Tablets; Global Pharmaceuticals Division to Launch
03 Apr 2006 Teva Announces Approval Of Deferoxamine Mesylate For Injection USP
30 Mar 2006 Bionutrics Announces the Initiation of Its Second US Development for a Generic Oral Controlled-Release Drug
24 Mar 2006 Taro Receives Tentative Approval for Terbinafine HCl Cream 1% ANDA; Generic Equivalent to Lamisil(R) Cream
16 Mar 2006 Taro Receives Final Approval for Mometasone Furoate Topical Solution USP, 0.1% (Lotion) ANDA; Generic Equivalent to Elocon(R) Lotion
09 Mar 2006 American Pharmaceutical Partners Receives Two Tentative FDA Approvals for Ondansetron Injection, USP
08 Mar 2006 European Medicines Agency finalises set of guidelines on similar biological medicines and publishes two more new concept papers
08 Mar 2006 Perrigo Company Announces Approval For Ciclopirox Olamine Cream
07 Mar 2006 Teva Announces Tentative Approval of Topiramate Tablets, 50 Mg
27 Feb 2006 Teva Announces Tentative Approval of Ondansetron Injection USP
25 Feb 2006 Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Fluvoxamine Maleate Tablets
24 Feb 2006 BioPartners Announces CHMP Positive Opinion for its Biosimilar Recombinant Human Growth Hormone - Valtropin™
23 Feb 2006 Mylan Announces Tentative Approval for Carvedilol Tablets
23 Feb 2006 Mayne Pharma reports increased sales and earnings and provides business review update
23 Feb 2006 Perrigo Company Announces Tentative Approval For Sertraline Hydrochloride Tablets
17 Feb 2006 American Pharmaceutical Partners Receives FDA Approval for Carboplatin Injection, 600 mg
16 Feb 2006 American Pharmaceutical Partners Receives Two FDA Approvals for Ceftriaxone for Injection, USP, Maintaining Company's Leadership Position in the Cephalosporin Market
16 Feb 2006 Teva Announces Tentative Approval of Rabeprazole Sodium Delayed-Release Tablets
14 Feb 2006 Teva Announces Tentative Approval of Adenosine Injection
14 Feb 2006 American Pharmaceutical Partners Receives Two FDA Approvals for Octreotide Acetate Injection
07 Feb 2006 Mylan Announces FDA Approval for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 351 - 400 of 409

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Emerging Diabetes Drugs

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics